KALA BIO, Inc.
KALA
$2.93
-$0.16-5.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 686.00K | -7.56M | -11.16M | -8.95M | -8.18M |
| Total Depreciation and Amortization | 54.00K | 128.00K | 67.00K | 68.00K | 69.00K |
| Total Amortization of Deferred Charges | -1.14M | 116.00K | 173.00K | 186.00K | 299.00K |
| Total Other Non-Cash Items | -2.77M | -1.28M | 2.49M | 2.42M | 2.18M |
| Change in Net Operating Assets | -1.39M | -2.28M | 694.00K | -2.55M | 1.03M |
| Cash from Operations | -4.56M | -10.88M | -7.73M | -8.82M | -4.60M |
| Capital Expenditure | 0.00 | 1.00K | -16.00K | -- | -69.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 1.00K | -16.00K | -- | -69.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -19.92M | -30.00K | -2.53M | -28.00K | -5.03M |
| Issuance of Common Stock | 9.13M | 60.00K | 0.00 | 13.00K | 11.67M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 1.80M | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | -120.00K | 0.00 |
| Cash from Financing | -8.98M | 30.00K | -2.53M | -135.00K | 6.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.54M | -10.85M | -10.28M | -8.96M | 1.98M |